U.S. market Closed. Opens in 11 hours 59 minutes

ACB | Aurora Cannabis Inc. Stock Overview

(Stock Exchange: NASDAQ)
Day's Range 5.77 - 6.09
52 Week Range 2.8400 - 9.35
Beta 0.55
Implied Volatility 88.26%
IV Rank 24.12%
Day's Volume 698,561
Average Volume 1,406,630
Shares Outstanding 54,660,800
Market Cap 319,765,680
Sector Healthcare
Industry Drug Manufacturers - Specialty & Generic
IPO Date 2014-07-15
Valuation
Profitability
Growth
Health
P/E Ratio -12.72
Forward P/E Ratio N/A
EPS -0.46
1YR Price Target N/A
Dividend Yield N/A
Dividend Per Share N/A
Dividend ExDate N/A
Dividend PayDate N/A
Employees 1,073
Country Canada
Website ACB
Aurora Cannabis Inc. produces, distributes, and sells cannabis and cannabis derivative products in Canada and internationally. It also engages in facility engineering and design, cannabis breeding, research, production, derivatives, product development, wholesale, and retail distribution activities. The company produces various strains of dried cannabis, cannabis oil and capsules, and topical kits for medical patients. It also sells vaporizers; consumable vaporizer accessories; and herb mills for using CanniMed herbal cannabis products, as well as grinders and vaporizer lockable containers. In addition, the company engages in the development of medical cannabis products at various stages of development, including oral, topical, edible, and inhalable products; and operation of CanvasRX, a network of cannabis counseling and outreach centers. Further, it provides patient counselling services; design and construction services; and cannabis analytical product testing services. The company's brand portfolio includes Aurora, Aurora Drift, San Rafael '71, Daily Special, AltaVie, MedReleaf, CanniMed, Whistler, Woodstock, and WMMC. Aurora Cannabis Inc. is headquartered in Edmonton, Canada.
ACB's peers: CGC, SNDL, HEXO, CRON, CURLF, OGI, TLRY, DERM, ZOM, TEVA, BGXX
*Chart delayed
Analyzing fundamentals for ACB we got that it has weak fundamentals where Valuation is considered to be significantly overvalued, Profitability is unacceptably poor, Growth is desperately bad and Health is very weak. For more detailed analysis please see ACB Fundamentals page.

Watching at ACB technicals we can see that long-term trend is bullish, while middle-term trend is bearish, as well as bearish short-term trend. More technicals details can be found on ACB Technicals page.
An error has occurred. This application may no longer respond until reloaded. Reload 🗙